45715-08-0 Usage
Uses
Used in Pharmaceutical Industry:
(5-METHYLPYRIDIN-2-YL)METHANAMINE is used as a building block for the production of drugs, contributing to the development of new pharmaceuticals with diverse therapeutic applications. Its unique structure allows it to be a key component in the creation of molecules with specific pharmacological properties.
Used in Chemical Industry:
In the chemical industry, (5-METHYLPYRIDIN-2-YL)METHANAMINE is utilized as a precursor for the synthesis of various organic compounds, including agrochemicals and other fine chemicals. Its ability to form a range of derivatives makes it invaluable for enhancing the properties of end products in this sector.
Used in Research and Development:
(5-METHYLPYRIDIN-2-YL)METHANAMINE is also used as a research compound for studying its potential pharmacological properties. Scientists are exploring its therapeutic uses, which could lead to the discovery of new treatments and applications in medicine.
Overall, (5-METHYLPYRIDIN-2-YL)METHANAMINE is a multifaceted chemical with a broad spectrum of applications across different industries, underpinning its importance in modern chemical synthesis and pharmaceutical development.
Check Digit Verification of cas no
The CAS Registry Mumber 45715-08-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,5,7,1 and 5 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 45715-08:
(7*4)+(6*5)+(5*7)+(4*1)+(3*5)+(2*0)+(1*8)=120
120 % 10 = 0
So 45715-08-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H10N2/c1-6-2-3-7(4-8)9-5-6/h2-3,5H,4,8H2,1H3
45715-08-0Relevant articles and documents
PYRROLOPYRAZINE KINASE INHIBITORS
-
Page/Page column 104; 105, (2013/03/28)
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.